(c) 2024 PillSync.com

clonidine hydrochloride tablet extended release

1 INDICATIONS AND USAGE Clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14) ] . Clonidine hydrochloride extended-release tablets are a centrally acting alpha 2 -adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications. ( 1 )

actavis pharma, inc.


3 years ago ROUND PINK logo 241 clonidine hydrochloride tablet extended release

ROUND PINK logo 241

3 years ago ROUND PINK logo 241 clonidine hydrochloride tablet extended release

logo 241 ROUND PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

CLONIDINE HYDROCHLORIDE Extended-Release Tablets, USP are supplied as follows: 0.1 mg — Each pink, round, unscored tablet debossed with on one side and 241 on the other side contains 0.1 mg of

CLONIDINE HYDROCHLORIDE, USP. Tablets are supplied in bottles of 60 (NDC 0228-4241-06). Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). See USP Controlled Room Temperature. Brands listed are the trademarks of their respective owners. Dispense in a tight, light-resistant container as defined in the USP. bceb3bbb-figure-05


More pills like ROUND logo 241

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site